14 reports

TUBERCULOSIS AND HIV.

  • Hepatitis Treatment
  • East Asia
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • ViiV Healthcare Ltd.

These include malaria, tuberculosis, cholera, meningitis and a number of sexually-transmitted infections.

  • Hepatitis Treatment
  • Pharmaceutical
  • Brazil
  • Demand
  • GlaxoSmithKline plc
  • 17.1 COMPETITIVE SCENARIO

The CDC reported that ##, ## people had tuberculosis and ##, ## individuals had Salmonella and Lyme disease in the country in 2011.

  • Hepatitis Treatment
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Bristol-Myers Squibb Company ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Bukwang Pharm Co Ltd ## ## ## ## ## ##

  • Hepatitis
  • Hepatitis Treatment
  • Infectious Disease
  • World
  • GlaxoSmithKline plc

It also develops active compounds against malaria, influenza A and B, brincidofovir for smallpox, dengue virus and tuberculosis, brincidofovir and adenovirus, among others.

  • Hepatitis Treatment
  • Pharmaceutical
  • United States
  • Company
  • ContraVir Pharmaceuticals, Inc.

One unit refers to one test kit.

  • Clinical Trial
  • Hepatitis
  • Hepatitis Treatment
  • RNA
  • Abbott

It is currently in Phase ## clinical development.

  • Hepatitis Treatment
  • United States
  • World
  • Forecast
  • Gilead Sciences, Inc.
  • CIPLA LIMITED: COMPANY HISTORY

Year 2015 : Contracts/ Agreements; Cipla was awarded a $## million tender for antiretroviral drugs by The Global Fund to Fight AIDS, Tuberculosis and Malaria.

  • Hepatitis Treatment
  • Pharmaceutical
  • India
  • Company
  • Cipla Ltd
  • RBT-05 - DRUG PROFILE

TUBERCULOSIS FATTY ACID PRODUCTION AND ENERGY STORAGE THUS REPRESENTING PROMISING ANTIBIOTIC TARGETS.

  • Hepatitis
  • Hepatitis Treatment
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company
  • RBT-05 - DRUG PROFILE

Its pipeline product portfolio includes PnuBioVax against invasive Streptococcus pneumoniae; MenBioVax for Neisseria meningitides; T-BioVax against tuberculosis (TB).

  • Antiviral
  • Hepatitis
  • Hepatitis Treatment
  • Therapy
  • Bristol-Myers Squibb Company
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

The prominent features of this report are - ##.

  • Cytokine
  • Digestive System Disorder
  • Hepatitis Treatment
  • Pharmaceutical
  • World

TUBERCULOSIS AND HCV CO INFECTION ##. ## AVOIDANCE OF HCV INFECTION HBV AND HCV CO INFECTION ##.

  • Hepatitis
  • Hepatitis Treatment
  • Therapy
  • World
  • Gilead Sciences, Inc.
  • Clinical Trial profile. 2165 Trial Title
  • Clinical Trial profile. 3499 Trial Title

Hepatitis Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis. Report includes an overview of trial...

  • Clinical Trial
  • Drug Discovery And Development
  • Hepatitis Treatment
  • Pharmaceutical
  • World

The company focuses on the development of recombinant proteins, artificial immunogens and antibody technologies, and tuberculosis vaccine.

  • Antiviral
  • Hepatitis Treatment
  • United States
  • Product Initiative
  • Gilead Sciences, Inc.